reference/31545422

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31545422

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1103
issn	0003-4967
issueIdentifier	8
pageRange	1096-1103
publicationName	Annals of the Rheumatic Diseases
startingPage	1096
bibliographicCitation	Schiff M, Keiserman M, Codding C, Songcharoen S, Berman A, Nayiager S, Saldate C, Li T, Aranda R, Becker J, Lin C, Cornet PLN, Dougados M. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate. Annals of the Rheumatic Diseases. 2008 Aug 01;67(8):1096–103. doi: 10.1136/ard.2007.080002.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bd754178353777c0856d28a7272d018 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef8341ae1e83dedf7a4678515cafc508 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d560815285867d5489573623b3dbdd67 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_570656869f1f869217b8f556f974eb08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_beed13d1286a73cfa744cf41cc627666 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ddf0f421b99a43f1d8002a5e5b86337 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_952ba95e0bcdb6e4a823d5f3b9a7165b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef716236a3f7bff7a4cc09661accbbb6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbd5dfe975a9d5749a10bf2162ad24fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8deb8b95d055e62fe560b0148b7433ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e303e59c50f3c27b6322ed05116c5645 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb710dfc13cee6c5e9659fe3bf06297d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebb8e81d69cf4a1b02df82c890de6bd8
date	2008-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/18055472 https://doi.org/10.1136/ard.2007.080002 https://pubmed.ncbi.nlm.nih.gov/PMC2564802
isPartOf	https://portal.issn.org/resource/ISSN/0003-4967 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/640
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
discusses	http://id.nlm.nih.gov/mesh/M0016932 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0028142 http://id.nlm.nih.gov/mesh/M0011171 http://id.nlm.nih.gov/mesh/M0013595 http://id.nlm.nih.gov/mesh/M0442852 http://id.nlm.nih.gov/mesh/M0282056 http://id.nlm.nih.gov/mesh/M0027742
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D018796Q000627 http://id.nlm.nih.gov/mesh/D001172Q000188 http://id.nlm.nih.gov/mesh/D007166Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012449 http://id.nlm.nih.gov/mesh/D000911Q000009 http://id.nlm.nih.gov/mesh/D000069594 http://id.nlm.nih.gov/mesh/D001799 http://id.nlm.nih.gov/mesh/D000704 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D000069285 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D017211 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D008727Q000627 http://id.nlm.nih.gov/mesh/D001172Q000523 http://id.nlm.nih.gov/mesh/D018796Q000009 http://id.nlm.nih.gov/mesh/D001172Q000276 http://id.nlm.nih.gov/mesh/D010919 http://id.nlm.nih.gov/mesh/D018501Q000627 http://id.nlm.nih.gov/mesh/D007166Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8686 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9109 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681276 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129756062 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129509037

Total number of triples: 76.